BamSEC and AlphaSense Join Forces
Learn More

Ligand Pharmaceuticals Incorporated

NASDAQ: LGND    
Share price (12/20/24): $114.64    
Market cap (12/20/24): $2.166 billion
Search in Documents
Key Exhibits
External Links

Articles of Incorporation Filter

EX-3.1
from 8-K 30 pages Fifth Amended and Restated Bylaws of Ligand Pharmaceuticals Incorporated
12/34/56
EX-3.1
from 8-K 31 pages Fourth Amended and Restated Bylaws of Ligand Pharmaceuticals Incorporated
12/34/56
EX-3.6
from S-8 1 page Certificate of Amendment of the Amended and Restated Certificate of Incorporation of Ligand Pharmaceuticals Incorporated a Delaware Corporation
12/34/56
EX-3.1
from 8-K 21 pages Third Amended and Restated Bylaws of Ligand Pharmaceuticals Incorporated
12/34/56
EX-3.1
from 8-K ~10 pages Second Amended and Restated Bylaws of Ligand Pharmaceuticals Incorporated
12/34/56
EX-3.1
from 8-K 1 page Certificate of Amendment of the Amended and Restated Certificate of Incorporation of Ligand Pharmaceuticals Incorporated a Delaware Corporation
12/34/56
EX-3
from 8-K 1 page Amendment of Bylaws of Ligand Pharmaceuticals Inc.
12/34/56
EX-3
from 8-K 1 page Bylaws Amendment
12/34/56
EX-3.(I)
from 10-Q 1 page Articles of Incorporation or Bylaws
12/34/56
EX-3.5
from 10-K 1 page Articles of Incorporation or Bylaws
12/34/56
EX-3
from SC 13D/A 1 page Letter Agreement
12/34/56
EX-3.3
from 10-Q 1 page Articles of Incorporation or Bylaws
12/34/56
EX-3.3
from S-4 ~20 pages Articles of Incorporation or Bylaws
12/34/56
EX-3.2
from S-4 ~5 pages Articles of Incorporation or Bylaws
12/34/56
EX-3.1
from S-4 ~10 pages Articles of Incorporation or Bylaws
12/34/56
EX-3.1
from S-3/A ~5 pages Articles of Incorporation or Bylaws
12/34/56
EX-3
from SC 13D 1 page Second Addendum to Registration Rights
12/34/56